Rowinsky, E K <br/><br/>
Hexamethylene bisacetamide in myelodysplastic syndrome: effect of five-day exposure to maximal therapeutic concentrations.  [electronic resource] 

 -  Leukemia  Jun 1992 
 - 526-34 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0887-6924 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetamides--administration & dosage<br/>Adult<br/>Aged<br/>Algorithms<br/>Cell Division--drug effects<br/>Depression, Chemical<br/>Drug Administration Schedule<br/>Female<br/>Hematinics--administration & dosage<br/>Hematopoietic Stem Cells--drug effects<br/>Humans<br/>Leukopenia--chemically induced<br/>Male<br/>Middle Aged<br/>Myelodysplastic Syndromes--blood<br/>Survival Rate<br/>Thrombocytopenia--chemically induced